Proxisome prolifrator-activated receptors alpha and delta in diabetic cardiomyopathy

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 53

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PBRE-1-4_001

تاریخ نمایه سازی: 10 دی 1402

Abstract:

Peraxisome prolifrator-activated receptors (PPARs) are a group of nuclear receptors comprising three isoforms termed alpha, beta/delta and gamma. PPARs can modulate metabolic processes especially fatty acid (FA) metabolisms via exerting transcriptional control on activating genes involved in fuel utilization. Thus, they can exert positive role in controlling chronic diseases such as diabetes. As development of diabetes leads to functional and structural alterations at the myocardium termed diabetic cardiomyopathy (DCM), metabolic controller seems to be able to affect on cardiomyocytes. Herein, the role of PPARα, and PPARδ, is emerged and compared. This minireview discusses about these receptors in diabetes.

Keywords:

Peraxisome prolifrator-activated receptors (PPARs) , metabolic processes , Fatty acid (FA) , diabetic cardiomyopathy (DCM) , PPARα , PPARδ

Authors

Mahkameh Soltani

Pharmaceutical sciences research center,Hemglobinopathy Institute,Mazandaran Univesrsity of Medical Sciences,Sari Iran

Ramin Ataee

Pharmaceutical sciences research center,Hemglobinopathy Institute,Mazandaran Univesrsity of Medical Sciences,Sari Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A. ...
  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the ...
  • Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of ...
  • Van der Vusse GJ, Glatz JF, Stam HC, Reneman RS. ...
  • Lopaschuk GD. Metabolic abnormalities in the diabetic heart. Heart Failure ...
  • Bertrand L, Horman S, Beauloye C, Vanoverschelde JL. Insulin Signaling ...
  • Saunders J, Mathewkutty S, Drazner MH, McGuire DK. Cardiomyopathy in ...
  • Neher MD, Weckbach S, Huber-Lang MS, Stahel PF. New insights ...
  • DiRenzo J, Söderstrom M, Kurokawa R, Ogliastro MH, Ricote M, ...
  • Varga T, Czimmerer Z, Nagya L. PPARs are a unique ...
  • Harvey PA, Leinwand LA. The cell biology of disease: cellular ...
  • Arimura T, Hayashi T, Kimura A. Molecular etiology of idiopathic ...
  • Umlauf J, Horký M. Molecular biology of doxorubicin-induced cardiomyopathy. Exp ...
  • DeAtley SM, Aksenov MY, Aksenova MV, Jordan B, Carney JM, ...
  • Abdel-aleem S, el-Merzabani MM, Sayed-Ahmed M, Taylor DA, Lowe JE. ...
  • Sisakian H. Cardiomyopathies: Evolution of pathogenesis concepts and potential for ...
  • Report of the WHO/IFSC Task Force on the Definition and ...
  • Bryant NJ, Govers R, James DE. Regulated transport of the ...
  • Sophie E L, Tavare JM. The molecular basis of insulin-stimulated ...
  • Mîinea CP, Sano H, Kane S, Sano E, Fukuda M, ...
  • Peck GR, Chavez JA, Roach WG, Budnik BA, Lane WS, ...
  • Meshkani R, Adeli Kh. Mechanisms Linking the Metabolic Syndrome andCardiovascular ...
  • Yu C, Chen Y, Cline GW, Zhang D, Zong H, ...
  • Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky GM. Increased malonyl-CoA ...
  • Wang, S.P. Devaiah, W. Zhang, R. Welti, Signaling functions of ...
  • Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by ...
  • Turban S, Hajduch E. Protein kinase C isoforms: mediator of ...
  • Samuel VT, Peterson KF, Shulman GI. Lipid induced insulin resistance: ...
  • Idris I, Gray S, Donnelly R. Protein kinase C activation: ...
  • Li YT, Soos TJ, Li X, Wu J, Degennaro M, ...
  • Werner ED, Lee J, Hansen L, Yuan M, Shoelson SE. ...
  • Ikeda Y, Olsen GS, Ziv E, Hansen LL, Busch AK, ...
  • Mack E, Ziv E, Reuveni H, Kalman R, Niv MY, ...
  • Stratford, D.B. DeWald, S.A. Summers, Ceramide dissociates ۳′-phosphoinositide production from ...
  • Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, ...
  • Azzam R, Hariri F, El-Hachem N, Kamar A, Dbaibo G, ...
  • Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: ...
  • نمایش کامل مراجع